... ENG

SABCS 2022 - Antibody-drug conjugates were blockbusters in 2022 for treatment of advanced breast cancer

Created by oncoXchange | December 14th 2022

SABCS 2022 - Early breast cancer year in review addresses treatment outcomes in various subtypes

Created by oncoXchange | December 15th 2022

WOO Series

WOO SERIES - How do WOOs contribute to research – individually and collectively, why are they valuable?

With Dr. Melanie Spears

WOO Series

WOO SERIES - WOO presurgical trials - a Clinician’s perspective

With Dr. Angel Arnaout MD MSC FRCSC MBA

CLINICAL IMPACT Series

ESMO 2022 Breast Cancer : Clinical Impact on Your Practice

Review of ESMO 2022 data in Breast Cancer with Dr. Jamil Asselah, Dr. Rami J. Younan & Dr. Nicholas Meti

CLINICAL IMPACT Series

CLINICAL IMPACT - Genetic testing for breast cancer patients in Quebec: Why, how and whom?

Session moderated by Dr. Rami Younan, featuring Nathalie Bolduc, Genetic Counsellor and Dr. Julie Lemieux, Hematologist and Medical Oncologist.

WOO Series

WOO SERIES - Patients perspectives on WOOs as a clinical research tool

Interview of Patient Carol Gordon, CPA, CFA by Dr.Angel Arnaout, MD MSC FRCSC MBA

CLINICAL IMPACT Series

SABCS 2022 Breast Cancer : Clinical Impact on Your Practice

Review of SABCS 2022 data in Breast Cancer with Dr. Jamil Asselah, Dr. Sara Soldera and Dr. Julie Lemieux